Shares of Beyond Meat (BYND) fell approximately 14% in early trading Thursday after the plant-based protein company issued second-quarter revenue guidance that fell short of Wall Street expectations. Management forecast sales between $60 million and $65 million, below the $67 million consensus estimate compiled by LSEG. The stock was trading near $0.89 per share.
First-Quarter Results Show Continued Weakness
The company reported first-quarter revenue of $58.2 million, a decline of 15.3% year-over-year, driven by a 19.5% drop in product volume. U.S. retail sales fell 15.3%, while U.S. foodservice revenue plunged 29.7%. International foodservice also saw a sharp decline of 25.9%, pressured by reduced demand for burgers and chicken from fast-food partners. However, international retail revenue posted an 8.1% gain, supported by stronger demand in Europe and firmer pricing.
Cost Improvements Narrow Losses
Gross margin improved to positive 3.4%, recovering from negative 10.1% in the same period last year. The net loss narrowed to $28.5 million, compared to a loss of $61.1 million a year ago. Adjusted EBITDA loss was $27.8 million, better than the $50.5 million loss in the prior year. CEO Ethan Brown highlighted the quarter as a period of "lowest quarterly cash use in over two years," but acknowledged that revenue challenges remain the primary focus.
Strategic Pivot to Functional Beverages
Beyond Meat is repositioning itself as "Beyond The Plant Protein Company," expanding beyond its core meat alternatives into functional food and beverages. The company launched Beyond Immerse, a sparkling plant-protein drink containing 20 grams of protein, 7 grams of fiber, and 100 calories per serving. Through a distribution agreement with Big Geyser, the beverage will be available in over 26,000 retail locations across the New York metro area. "Unlike anything else in our portfolio," said Jerry Reda, President and COO of Big Geyser.
Balance Sheet Under Pressure
As of quarter-end, Beyond Meat held $205.8 million in cash and restricted cash, with debt carrying value of $411.6 million. After the quarter, $62.6 million in convertible notes due 2030 were converted into common stock, resulting in the issuance of over 52 million shares. The company also noted that it no longer meets the requirements for its at-the-market equity offering program, limiting access to additional equity funding.
Wall Street Skepticism Persists
Barclays maintained its Underweight rating and $0.50 price target on Beyond Meat, citing ongoing operating losses and sluggish demand for plant-based meat. The analyst noted that the new beverage line may not scale quickly enough to offset declines in the core business. The company faces multiple risks, including further demand erosion, potential confusion from the rebrand, consumer rejection of new products, and debt constraints.
Broader Market Context
The plant-based protein sector is seeing increased competition as companies like Eat Just, Impossible Foods, and Silk launch new protein-rich products. Beyond Meat's pivot into functional beverages reflects broader industry trends toward protein fortification. CEO Brown stated that there is "considerable ground left to cover" on profitability, but emphasized that the company is not waiting to expand into adjacent categories.
